Core Viewpoint - The stock of Ailis has experienced a decline of 2.00% on October 23, 2023, with a current price of 103.17 CNY per share, despite a year-to-date increase of 74.57% [1] Financial Performance - For the first half of 2025, Ailis reported a revenue of 2.374 billion CNY, representing a year-on-year growth of 50.57%, and a net profit attributable to shareholders of 1.051 billion CNY, which is a 60.22% increase compared to the previous period [2] Shareholder Information - As of June 30, 2025, the number of Ailis shareholders increased by 3.61% to 13,000, while the average number of circulating shares per person decreased by 3.48% to 34,578 shares [2] - The company has distributed a total of 653 million CNY in dividends since its A-share listing [3] Institutional Holdings - Among the top ten circulating shareholders as of June 30, 2025, Huaxia SSE STAR 50 ETF is the fifth largest with 12.42 million shares, an increase of 1.32 million shares from the previous period [3] - Hong Kong Central Clearing Limited is the seventh largest shareholder with 10.38 million shares, a decrease of 246,090 shares [3] - E Fund SSE STAR 50 ETF ranks ninth with 9.31 million shares, an increase of 26,090 shares, while China Europe Medical Health Mixed A is a new entrant in the top ten with 9.15 million shares [3]
艾力斯跌2.00%,成交额1.45亿元,主力资金净流出546.40万元